Clinical Trial Update: Cryopreserved-thawed Embryo Transfer With or Without Gonadotropin Releasing Hormone Agonist [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating cryopreserved-thawed embryo transfer with or without a gonadotropin-releasing hormone (GnRH) agonist has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• Gonadotropin-releasing hormone (GnRH) agonist (gonadotropin-releasing hormone agonist)

Snippet

Sponsor: Cairo University | Conditions: Infertility | Phase 3 | Status: COMPLETED